Literature DB >> 7895289

Stimulation of the ATP-dependent interaction between actin and myosin by a myosin-binding fragment of smooth muscle caldesmon.

Y Lin1, R Ishikawa, T Okagaki, L H Ye, K Kohama.   

Abstract

We reported previously that smooth muscle caldesmon stimulates the ATP-dependent interaction between actin and phosphorylated smooth muscle myosin, as monitored by ATPase measurement and in vitro motility assay. Furthermore, this effect changes from stimulatory to inhibitory with increasing concentrations of caldesmon [Ishikawa et al., 1991: J. Biol. Chem. 266:21784-21790]. The N-terminal (myosin-binding) fragment and the C-terminal (actin-binding) fragment were purified from digests of caldesmon. The effects of the myosin-binding fragment and the actin-binding fragment on the interaction were stimulatory and inhibitory, respectively, indicating that stimulatory and inhibitory domains are localized in the myosin-binding domain and actin-binding domain of caldesmon, respectively. The effect of the myosin-binding fragment on the interaction was exclusively stimulatory when the interaction was challenged by caldesmon, both at lower and higher concentrations. However, the actin-binding fragment had no effect on the interaction at lower concentrations and inhibited the interaction at higher concentrations. Thus, the stimulatory effect of caldesmon that is observed at lower concentrations can be explained by the hypothesis that the stimulatory effect of the myosin-binding domain predominates over the inhibitory effect of the actin-binding domain when the concentration of caldesmon is low. With uncleaved caldesmon, we also emphasized the role of the myosin-binding domain in the stimulation as follows; the stimulatory effect of caldesmon became obscured when binding of caldesmon to myosin was competed by the exogenous caldesmon-binding fragment of myosin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7895289     DOI: 10.1002/cm.970290308

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  7 in total

1.  Myosin light-chain kinase of smooth muscle stimulates myosin ATPase activity without phosphorylating myosin light chain.

Authors:  L H Ye; H Kishi; A Nakamura; T Okagaki; T Tanaka; K Oiwa; K Kohama
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Myosin light chain kinase from skeletal muscle regulates an ATP-dependent interaction between actin and myosin by binding to actin.

Authors:  K Fujita; L H Ye; M Sato; T Okagaki; Y Nagamachi; K Kohama
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  Role of the short isoform of myosin light chain kinase in the contraction of cultured smooth muscle cells as examined by its down-regulation.

Authors:  Jianjun Bao; Kazuhiko Oishi; Tomohisa Yamada; Liqun Liu; Akio Nakamura; Masaatsu K Uchida; Kazuhiro Kohama
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-26       Impact factor: 11.205

4.  RNA sequencing identifies upregulated kyphoscoliosis peptidase and phosphatidic acid signaling pathways in muscle hypertrophy generated by transgenic expression of myostatin propeptide.

Authors:  Yuanxin Miao; Jinzeng Yang; Zhong Xu; Lu Jing; Shuhong Zhao; Xinyun Li
Journal:  Int J Mol Sci       Date:  2015-04-09       Impact factor: 5.923

5.  Modulatory effects of taurine on jejunal contractility.

Authors:  Q Y Yao; D P Chen; D M Ye; Y P Diao; Y Lin
Journal:  Braz J Med Biol Res       Date:  2014-10-14       Impact factor: 2.590

6.  Ardipusilloside-I stimulates gastrointestinal motility and phosphorylation of smooth muscle myosin by myosin light chain kinase.

Authors:  Zhili Xu; Hanye Liang; Mingbo Zhang; Xiaojun Tao; Deqiang Dou; Liping Hu; Tingguo Kang
Journal:  Korean J Physiol Pharmacol       Date:  2017-10-30       Impact factor: 2.016

7.  Calcium inhibition as an intracellular signal for actin-myosin interaction.

Authors:  Kazuhiro Kohama
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2016       Impact factor: 3.493

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.